Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-13

Clinical Trial Update: Phase 1b Study of Tizanidine in Pediatric Patients With Cerebral Palsy [Phase 1]

View source ↗

Summary

Phase 1b trial evaluating tizanidine for spasticity in pediatric cerebral palsy was terminated; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TIZANIDINE (TIZANIDINE)

Snippet

Sponsor: Acorda Therapeutics | Conditions: Spasticity Due to Cerebral Palsy | Phase 1 | Status: TERMINATED | Results posted: 2013-05-13